Visible Genomics, INC. logo

Visible Genomics

About

We see the future and we know that a better day is on the horizon. We've spent two decades in the genetic & diagnostic industry observing technological advancements transform the industry potential. Our mission is to arm patients and physicians with critical information and a look into the future, so that physicians can make informed decisions today that can have a lasting effect on their patients' long-term eye health. Visible Genomics offers a clinically validated state-of-the-art age-related macular degeneration (AMD) risk assessment.

Highlights

$26.4M
CF Valuation
$16.2K
Total Raised
$31.8K
Revenue
2
Employees

Indicators

Profit Margin
-1891.3%
(181.3%)
2022: -2072.6%
Current Ratio
0.01
(0%)
2022: 0.01

Revenue Growth